Laboratory

Discover our products

Clinical

Discovers our solutions

2 nouveaux établissements équipés avec CeGInaDis

Jun 16, 2017

Fédialis Médica a le plaisir de vous informer que les hôpitaux de la Pitié-Salpêtrière à Paris, ainsi que le CHU de Fort de France en Martinique utilisent notre logiciel CeGInaDis (version CeGIDD du logiciel NADIS) pour leurs activités de routine CeGIDD.
Read more
ABL Announces Distribution Agreement with BADER SULTAN & BROTHERS CO W.L.L

Jun 09, 2017

Advanced Biological Laboratories (ABL) S.A. and BADER SULTAN & BROTHERS CO W.L.L are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Kuwait. See current channel partners.
Read more
In June Save Up to 20% on all DeepChek® Assays for HIV and HCV

May 31, 2017

I’m interested!
Read more

Annonce d’un nouveau partenariat AFRAVIH – Fédialis Médica

May 23, 2017

Fédialis Médica a le plaisir de vous informer de la signature d’un partenariat avec l’AFRAVIH (www.afravih.org/) dans le but de tester l’utilisation du dossier médical informatisé NADIS pour le suivi et la prise en charge de patients vivant avec une pathologie chronique (VIH, hépatite, t…
Read more
SEQHEPB V6 – The Largest HBV Interpretation System & Database

May 17, 2017

ABL is pleased to announce the official release of its SeqHepB v6 interpretation system & database. Dedicated to the management of Viral Hepatitis B (HBV) sequencing data, the software can handle Capillary Electrophoresis or Next Generation Sequencing data, performs genotyping and mutation detec…
Read more
Renewal and Extension of the partnership with ThermoFisher around virology genotyping.

May 02, 2017

ABL is pleased to announce the renewal and the extension of the Reseller rights given to ThermoFisher to promote ABL’s Capillary Electrophoresis sequencing data analysis software (ViroScore®), on a worldwide basis (except Spain). The platform is intended to be used for genotyping in Vir…
Read more

Studies on DeepChek®-HCV Assays presented at the EASL 2017

Apr 24, 2017

“Evaluation of a sequence-based method for hepatitis C genotyping (DeepChek® SingleRound PCR and NS5B/5’UTR sequencing) and comparison with VERSANT HCV Genotype 2.0 assay (InnoLiPA)” – Greet J. Boland et al. – EASL 2017 – See poster “Retreatment with Direct…
Read more
New patent issued in Hong Kong around HBV resistance announced!

Apr 11, 2017

Advanced Biological Laboratories has been granted additional patents in Hong Kong (HK1121187) to further protect its intellectual property and reinforce the already existing core patent entitled ” Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications th…
Read more
ABL Welcomes You at the EASL in Amsterdam (April 19th – 22nd 2017)

Apr 11, 2017

Our team will provide information on our portfolio: Laboratories, virologists and microbiologists: DeepChek® Assays (Genotyping & Drug Resistance) UltraGene® Assays (Viral Load Detection) DeepChek®, SeqHepB® (Software systems for Sanger or NGS sequencing data management) Application: HBV, HCV… C…
Read more